Detailansicht

Wissensnetz

Person

Bertram Bengsch (1982-)

Arzt

Name	Bertram Bengsch
Zeit	1982- (Lebensdaten)
Ort	Singen (Hohentwiel) (Geburtsort) Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Dr. (an der Fakultät für Biologie der Universität Freiburg (Breisgau)) (2013)
Beruf	Arzt (charakteristischer Beruf)
Variante	Bertram Rüdiger Bengsch
Weitere Angaben	Diss. Universität Freiburg, Medizinische Fakultät
Datensatztyp	Person
GND-Nummer	136789242
Datensatz-ID	136789242
Beteiligt an alle anzeigen Impact of ALDH1A1 expression in intrahepatic cholangiocellular carcinoma Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinoma Attenuated effector T cells are linked to control of chronic HBV infection High throughput spatial immune mapping reveals an innate immune scar in post-COVID-19 brains Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome Prostaglandin E2 controls the metabolic adaptation of T cells to the intestinal microenvironment AI-assisted high-throughput tissue microarray workflow Attenuated effector T cells are linked to control of chronic HBV infection Efficacy, safety and differential outcomes of immune‐chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: a multicenter real world cohort High throughput spatial immune mapping reveals an innate immune scar in post-COVID-19 brains Impaired SARS-CoV-2-specific CD8+ T cells after infection or vaccination but robust hybrid t cell immunity in patients with multiple myeloma MCAM is a prognostic biomarker in patients with liver cirrhosis and HCC Prostaglandin E2 controls the metabolic adaptation of T cells to the intestinal microenvironment Safety and preliminary efficacy of pembrolizumab following transarterial chemoembolization for hepatocellular carcinoma: the PETAL phase Ib study Senolytic therapy alleviates physiological human brain aging and COVID-19 neuropathology Harnessing CD3 diversity to optimize CAR T cells Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients Capillary electrophoresis mass spectrometry identifies new isomers of inositol pyrophosphates in mammalian tissues Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: a global, observational study Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8+T cells Friend or foe – Tc17 cell generation and current evidence for their importance in human disease Harnessing CD3 diversity to optimize CAR T cells Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristics Progression patterns and therapeutic sequencing following immune checkpoint inhibition for HCC : : an international observational study Senolytic therapy alleviates physiological human brain aging and COVID-19 neuropathology T cells in the heterogeneous tumour immune microenvironment of hepatocellular carcinoma: Implications for immune checkpoint inhibitor therapy Incidence and severity of immune-related hepatitis after dual checkpoint therapy is linked to younger age independent of herpes virus immunity COVID-19 mRNA booster vaccine induces transient CD8+ T effector cell responses while conserving the memory pool for subsequent reactivation High-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signature Distinct CD8 T Cell Populations with Differential Exhaustion Profiles Associate with Secondary Complications in Common Variable Immunodeficiency Neue Therapieoptionen beim HCC* COVID-19 mRNA booster vaccine induces transient CD8+ T effector cell responses while conserving the memory pool for subsequent reactivation Distinct CD8 T cell populations with differential exhaustion profiles associate with secondary complications in common variable immunodeficiency High-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signature Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma Incidence and severity of immune-related hepatitis after dual checkpoint therapy is linked to younger age independent of herpes virus immunity P328: Dynamic evolution of TCF3-PBX1 leukemias at the single-cell level under chemotherapy pressure Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: a real‐world study SARS-CoV-2-specific T-cell epitope repertoire in convalescent and mRNA-vaccinated individuals Single-cell protein and transcriptional characterization of epiretinal membranes from patients with proliferative vitreoretinopathy Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10 T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10 Neue Therapieoptionen beim HCC Imaging mass cytometry for high-dimensional tissue profiling in the eye A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS Adaptive subsets limit the anti-tumoral NK-cell activity in hepatocellular carcinoma Adaptive Subsets Limit the Anti-Tumoral NK-Cell Activity in Hepatocellular Carcinoma Engrailed 1 coordinates cytoskeletal reorganization to induce myofibroblast differentiation Imaging mass cytometry for high-dimensional tissue profiling in the eye In-depth molecular characterization of neovascular membranes suggests a role for hyalocyte-to-myofibroblast transdifferentiation in proliferative diabetic retinopathy Pre-existing immunity and vaccine history determine hemagglutinin-specific CD4 T cell and IgG response following seasonal influenza vaccination Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine TOX defines the degree of CD8+ T cell dysfunction in distinct phases of chronic HBV infection Vaccine-induced ICOS+CD38+ circulating Tfh are sensitive biosensors of age-related changes in inflammatory pathways Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells Mass cytometry - a tool for the curious: networking in Berlin

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Bertram Bengsch (1982-)

Impact of ALDH1A1 expression in intrahepatic cholangiocellular carcinoma

Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinoma

Attenuated effector T cells are linked to control of chronic HBV infection

High throughput spatial immune mapping reveals an innate immune scar in post-COVID-19 brains

Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome

Prostaglandin E2 controls the metabolic adaptation of T cells to the intestinal microenvironment

AI-assisted high-throughput tissue microarray workflow

Attenuated effector T cells are linked to control of chronic HBV infection

Efficacy, safety and differential outcomes of immune‐chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: a multicenter real world cohort

High throughput spatial immune mapping reveals an innate immune scar in post-COVID-19 brains

Impaired SARS-CoV-2-specific CD8+ T cells after infection or vaccination but robust hybrid t cell immunity in patients with multiple myeloma

MCAM is a prognostic biomarker in patients with liver cirrhosis and HCC

Prostaglandin E2 controls the metabolic adaptation of T cells to the intestinal microenvironment

Safety and preliminary efficacy of pembrolizumab following transarterial chemoembolization for hepatocellular carcinoma: the PETAL phase Ib study

Senolytic therapy alleviates physiological human brain aging and COVID-19 neuropathology

Harnessing CD3 diversity to optimize CAR T cells

Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma

Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma

Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients

Capillary electrophoresis mass spectrometry identifies new isomers of inositol pyrophosphates in mammalian tissues

Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: a global, observational study

Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8+T cells

Friend or foe – Tc17 cell generation and current evidence for their importance in human disease

Harnessing CD3 diversity to optimize CAR T cells

Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma

Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristics

Progression patterns and therapeutic sequencing following immune checkpoint inhibition for HCC : : an international observational study

Senolytic therapy alleviates physiological human brain aging and COVID-19 neuropathology

T cells in the heterogeneous tumour immune microenvironment of hepatocellular carcinoma: Implications for immune checkpoint inhibitor therapy

Incidence and severity of immune-related hepatitis after dual checkpoint therapy is linked to younger age independent of herpes virus immunity

COVID-19 mRNA booster vaccine induces transient CD8+ T effector cell responses while conserving the memory pool for subsequent reactivation

High-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signature

Distinct CD8 T Cell Populations with Differential Exhaustion Profiles Associate with Secondary Complications in Common Variable Immunodeficiency

Neue Therapieoptionen beim HCC*

COVID-19 mRNA booster vaccine induces transient CD8+ T effector cell responses while conserving the memory pool for subsequent reactivation

Distinct CD8 T cell populations with differential exhaustion profiles associate with secondary complications in common variable immunodeficiency

High-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signature

Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma

Incidence and severity of immune-related hepatitis after dual checkpoint therapy is linked to younger age independent of herpes virus immunity

P328: Dynamic evolution of TCF3-PBX1 leukemias at the single-cell level under chemotherapy pressure

Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: a real‐world study

SARS-CoV-2-specific T-cell epitope repertoire in convalescent and mRNA-vaccinated individuals

Single-cell protein and transcriptional characterization of epiretinal membranes from patients with proliferative vitreoretinopathy

Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma

T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10

T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10

Neue Therapieoptionen beim HCC

Imaging mass cytometry for high-dimensional tissue profiling in the eye

A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS

Adaptive subsets limit the anti-tumoral NK-cell activity in hepatocellular carcinoma

Adaptive Subsets Limit the Anti-Tumoral NK-Cell Activity in Hepatocellular Carcinoma

Engrailed 1 coordinates cytoskeletal reorganization to induce myofibroblast differentiation

Imaging mass cytometry for high-dimensional tissue profiling in the eye

In-depth molecular characterization of neovascular membranes suggests a role for hyalocyte-to-myofibroblast transdifferentiation in proliferative diabetic retinopathy

Pre-existing immunity and vaccine history determine hemagglutinin-specific CD4 T cell and IgG response following seasonal influenza vaccination

Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine

TOX defines the degree of CD8+ T cell dysfunction in distinct phases of chronic HBV infection

Vaccine-induced ICOS+CD38+ circulating Tfh are sensitive biosensors of age-related changes in inflammatory pathways

Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells

Mass cytometry - a tool for the curious: networking in Berlin